(Q72852050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Satisfactory separation and MS-MS spectrometry of six surfactins isolated from Bacillus subtilis natto (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

1 reference

(3S)-13-[(3S,6R,9S,12S,15R,18S,21S,25R)-21-(2-carboxyethyl)-9-(carboxymethyl)-3,6,15,18-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-25-yl]-3-hydroxytridecanoic acid

1 reference

1 reference

CSJRBDJGUADNET-LWLYRBPCSA-N

1 reference

(3S,12R)-12-[(3S,6R,9S,12S,15R,18S,21S,25S)-21-(2-carboxyethyl)-9-(carboxymethyl)-3,6,15,18-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-25-yl]-3-hydroxytridecanoic acid

reverse claim

1 reference

(3S,13R)-13-[(3S,6R,9S,12S,15R,18S,21S,25S)-21-(2-carboxyethyl)-9-(carboxymethyl)-3,6,15,18-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-25-yl]-3-hydroxytetradecanoic acid

reverse claim

1 reference

(3S,11R)-11-[(3S,6R,9S,12S,15R,18S,21S,25S)-21-(2-carboxyethyl)-9-(carboxymethyl)-3,6,15,18-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-25-yl]-3-hydroxydodecanoic acid

reverse claim

1 reference

1 reference

1 reference

K Oka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

T Hirano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M Homma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H Ishii

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

K Murakami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

S Mogami

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

A Motizuki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H Morita

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

K Takeya

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H Itokawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

language of work or name

English

1 reference

Chemical & Pharmaceutical Bulletin

publication date

1993

1 reference

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/cpb1958/41/5/41_5_1000/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.41.1000?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

1000-1002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.41.1000?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Revised structure of mycosubtilin, a peptidolipid antibiotic from Bacillus subtilis

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.39.636

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Antitumor Activity of Bacillus natto. III. Isolation and Characterization of a Cytolytic Substance on Ehrlich Ascites Carcinoma Cells in the Culture Medium of Bacillus natto KMD 1126

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Mode of action of iturin A, an antibiotic isolated from Bacillus subtilis, on Micrococcus luteus

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Identification of a genetic locus required for biosynthesis of the lipopeptide antibiotic surfactin in Bacillus subtilis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Pore-forming properties of iturin A, a lipopeptide antibiotic

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Identification of amino acid substitutions in the lipopeptide surfactin using 2D NMR spectroscopy

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Acylpeptides, the inhibitors of cyclic adenosine 3',5'-monophosphate phosphodiesterase. III. Inhibition of cyclic AMP phosphodiesterase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Antitumor activity of bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.22.938

Acylpeptides, the inhibitors of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Purification, physicochemical properties and structures of fatty acid residues

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Bacterial lipopeptides induce ion-conducting pores in planar bilayers

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Acylpeptides, the inhibitors of cyclic adenosine 3',5'-monophosphate phosphodiesterase. II. Amino acid sequence and location of lactone linkage

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1000

Identifiers

DOI

10.1248/CPB.41.1000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339332%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference